NANOBIOTIX Announces the Appointment of Arnd Christ as Chief Financial Officer

October 2, 2026 - 00:12

NANOBIOTIX has announced the appointment of Arnd Christ as its new chief financial officer, effective October 1, 2026. Christ joins the company with over twenty years of experience in financial leadership, bringing a wealth of knowledge and expertise to the executive board. His background includes significant roles in both public and private companies, where he has developed a strong track record in financial strategy and operational management.

In his new role, Christ will be responsible for overseeing the company's financial operations and will play a key role in shaping its financial strategy as it continues to advance its innovative approaches to cancer treatment. His experience in navigating complex financial landscapes will be invaluable as NANOBIOTIX seeks to expand its reach and enhance its capabilities in the biotechnology sector.

The company is excited about the prospects that Christ's leadership will bring, especially as it aims to push the boundaries of treatment possibilities for patients facing major diseases. His appointment marks a significant step forward for NANOBIOTIX in its mission to improve patient outcomes through cutting-edge technology.